Sudarshan Pharma Industries Ltd
Incorporated in 2008, Mumbai-based Sudarshan Pharma Industries Limited (SPIL) has a contract manufacturing facility for generic formulations. It is also engaged in import & export activities, and supply of specialty chemicals, API, and Intermediates[1]
- Market Cap ₹ 175 Cr.
- Current Price ₹ 72.6
- High / Low ₹ 91.9 / 62.0
- Stock P/E 20.8
- Book Value ₹ 43.7
- Dividend Yield 0.41 %
- ROCE 15.5 %
- ROE 11.0 %
- Face Value ₹ 10.0
Pros
- Debtor days have improved from 84.5 to 64.5 days.
Cons
- Company has a low return on equity of 13.5% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
|---|---|---|---|---|---|
| 148 | 193 | 357 | 461 | 498 | |
| 143 | 186 | 346 | 446 | 481 | |
| Operating Profit | 5 | 7 | 11 | 15 | 16 |
| OPM % | 3% | 4% | 3% | 3% | 3% |
| 0 | 0 | 0 | 1 | 3 | |
| Interest | 3 | 3 | 3 | 5 | 6 |
| Depreciation | 0 | 1 | 1 | 1 | 1 |
| Profit before tax | 2 | 4 | 7 | 9 | 11 |
| Tax % | 26% | 25% | 26% | 26% | |
| 1 | 3 | 5 | 7 | 8 | |
| EPS in Rs | 1.34 | 2.80 | 5.39 | 2.93 | 3.49 |
| Dividend Payout % | 0% | 0% | 0% | 10% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 46% |
| TTM: | 29% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 78% |
| TTM: | 36% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 5% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 14% |
| Last Year: | 11% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 24 | 24 |
| Reserves | 10 | 13 | 20 | 77 | 81 |
| 21 | 30 | 31 | 34 | 65 | |
| 18 | 47 | 77 | 97 | 95 | |
| Total Liabilities | 58 | 99 | 138 | 232 | 265 |
| 6 | 6 | 6 | 20 | 21 | |
| CWIP | 0 | 0 | 1 | 0 | 1 |
| Investments | 0 | 0 | 0 | 12 | 14 |
| 53 | 93 | 131 | 200 | 230 | |
| Total Assets | 58 | 99 | 138 | 232 | 265 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|
| 1 | 3 | -4 | -29 | |
| -3 | -1 | -1 | -26 | |
| -0 | -1 | 4 | 66 | |
| Net Cash Flow | -2 | -0 | -1 | 11 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|
| Debtor Days | 66 | 114 | 75 | 64 |
| Inventory Days | 46 | 49 | 51 | 63 |
| Days Payable | 40 | 91 | 80 | 78 |
| Cash Conversion Cycle | 72 | 72 | 46 | 50 |
| Working Capital Days | 69 | 69 | 54 | 71 |
| ROCE % | 15% | 19% | 15% |
Documents
Announcements
- Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 30 Apr
- Certificate Pursuant To Reg. 40(9) & 40(10) Of SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015. 25 Apr
-
Compliances-Compliance Certificate For The Period Ended March, 2024.
20 Apr - Compliance Certificate pursuant to Regulation 7(3) of SEBI (LODR) Regulations 2015.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
15 Apr - Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31st March 2024.
-
Announcement under Regulation 30 (LODR)-Change in Management
1 Apr - Sudarshan Pharma Industries Limited hereby intimates the Stock Exchange about the resignation of Ms. Ishita Samani from the position of Company Secretary and Compliance Officer …
Business Area
A) Specialty Chemicals, Intermediates & API[1] Co. is involved in Manufacturing, Imports of specialty chemicals & exports, as well as outsourcing & Supply of Specialty chemicals, bulk drugs, and API for domestic and international clients in Pharma, agrochemicals, Paints, resins & various industry.